ORIGINAL ARTICLE

Thyroid transcription factor 1 in pulmonary adenocarcinoma

G Stenhouse, N Fyfe, G King, A Chapman, K M Kerr

Aberdeen Royal Infirmary, Foresterhill, Aberdeen AB25 2ZD, UK

Correspondence to:
Correspondence to:
Dr K M Kerr
Department of Pathology, University Medical Building, University of Aberdeen, Aberdeen Royal Infirmary, Foresterhill, Aberdeen AB25 2ZD, UK; k.kerr{at}abdn.ac.uk

Aims: To discover whether variations in thyroid transcription factor 1 (TTF-1) staining in different subtypes and patterns of pulmonary adenocarcinoma are related to the putative origin of the tumour. In addition, to confirm the specificity of TTF-1 for pulmonary (as opposed to other sites) adenocarcinoma, to examine the possible prognostic relevance of TTF-1 positivity in lung cancer, and to review this laboratory’s experience of TTF-1 in diagnostic practice.

Materials/Methods: In total, 128 primary lung adenocarcinomas, 106 primary non-pulmonary adenocarcinomas, and 37 pulmonary non-adenocarcinoma tumours were studied. In addition, 100 cases where TTF-1 was used in routine surgical pathology practice were investigated. Immunoperoxidase staining was performed on formalin fixed, paraffin wax embedded sections using anti-TTF-1 antibody. Staining was evaluated semiquantitatively using the frequency and intensity of nuclear positivity.

Results: None of the 106 non-pulmonary adenocarcinomas expressed TTF-1 and only three of the 37 non-adenocarcinoma lung cancers, all neuroendocrine carcinomas, were positive. Of the pulmonary adenocarcinomas, 75% were strongly positive for TTF-1. Mucinous (two of six) and poorly differentiated adenocarcinomas (four of 10) were less likely to stain. Of the peripheral adenocarcinomas, 33 of 37 were positive, whereas only seven of 14 of those of bronchial origin stained strongly. Atypical adenomatous hyperplasia strongly expressed TTF-1. No "false positives" were encountered in the 100 routine diagnostic cases.

Conclusion: Positive TTF-1 staining is useful in the differential diagnosis of pulmonary adenocarcinomas. TTF-1 may be a lineage marker for tumours arising from the peripheral airway or alveolar epithelium and has no prognostic relevance.

Abbreviations: AAH, atypical adenomatous hyperplasia; BAC, bronchioloalveolar carcinoma; TTF-1, thyroid transcription factor 1; WHO, World Health Organisation

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Wang, C.-W., Wu, T.-I, Yu, C.-T., Wu, Y.-C., Teng, Y.-H., Chin, S.-Y., Lai, C.-H., Chen, T.-C. (2009). Usefulness of p16 for Differentiating Primary Pulmonary Squamous Cell Carcinoma From Cervical Squamous Cell Carcinoma Metastatic to the Lung. Am J Clin Pathol 131: 715-722 [Abstract] [Full Text]  
• Anagnostou, V. K., Syrigos, K. N., Bepler, G., Homer, R. J., Rimm, D. L. (2009). Thyroid Transcription Factor 1 Is an Independent Prognostic Factor for Patients With Stage I Lung Adenocarcinoma. JCO 27: 271-278 [Abstract] [Full Text]  
• Berghmans, T, Paesmans, M, Mascaux, C, Martin, B, Meert, A-P, Haller, A, Lafitte, J-J, Sculier, J-P (2006). Thyroid transcription factor 1--a new prognostic factor in lung cancer: a meta-analysis. Ann Oncol 17: 1673-1676 [Abstract] [Full Text]  
• Penman, D, Downie, I, Roberts, F (2006). Positive immunostaining for thyroid transcription factor-1 in primary and metastatic colonic adenocarcinoma: a note of caution.. J. Clin. Pathol. 59: 663-664 [Abstract] [Full Text]  
• Papi, G, Corrado, S, Carani, C, Asa, S L (2005). Metastasis of a caecal neuroendocrine carcinoma to the thyroid gland. J. Clin. Pathol. 58: 1342-1343 [Full Text]